Article info

Original research
Patients with mesenchymal tumours and high Fusobacteriales prevalence have worse prognosis in colorectal cancer (CRC)

Authors

  1. Correspondence to Professor Jochen H M Prehn, Department of Physiology and Medical Physics and Centre for Systems Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland; jprehn{at}rcsi.ie
View Full Text

Citation

Salvucci M, Crawford N, Stott K, et al
Patients with mesenchymal tumours and high Fusobacteriales prevalence have worse prognosis in colorectal cancer (CRC)

Publication history

  • Received May 18, 2021
  • Accepted August 31, 2021
  • First published September 8, 2021.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.